Literature DB >> 21680678

Raltegravir in pregnancy: a case series presentation.

N Taylor1, V Touzeau, M Geit, M Gisinger, A Egle, R Greil, A Rieger, R Zangerle.   

Abstract

Adequate antiretroviral therapy is essential for HIV-positive pregnant women to prevent mother-to-child transmission. We report a small case series of five women receiving raltegravir as part of their antiretroviral regimen during pregnancy.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21680678     DOI： 10.1258/ijsa.2011.010469

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


  6 in total

1.  Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women.

Authors:  Gail F Shust; Jennifer Jao; Gabriela Rodriguez-Caprio; Roberto Posada; Katherine T Chen; Amelia Averitt; Rhoda S Sperling
Journal:  J Pediatric Infect Dis Soc       Date:  2013-04-12       Impact factor: 3.164

2.  Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.

Authors:  Lisa Rahangdale; Jordan Cates; JoNell Potter; Martina L Badell; Dominika Seidman; Emilly S Miller; Jenell S Coleman; Gweneth B Lazenby; Judy Levison; William R Short; Sigal Yawetz; Andrea Ciaranello; Elizabeth Livingston; Lunthita Duthely; Bassam H Rimawi; Jean R Anderson; Elizabeth M Stringer
Journal:  Am J Obstet Gynecol       Date:  2016-03       Impact factor: 8.661

3.  Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.

Authors:  Isabella Nóbrega; Ana Gabriela Travassos; Tatiana Haguihara; Fábio Amorim; Carlos Brites
Journal:  AIDS Res Hum Retroviruses       Date:  2013-06-25       Impact factor: 2.205

4.  Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission.

Authors:  Thanyawee Puthanakit; Nattawan Thepnarong; Surasith Chaithongwongwatthana; Suvaporn Anugulruengkitt; Orawan Anunsittichai; Tuangtip Theerawit; Sasiwimol Ubolyam; Chitsanu Pancharoen; Praphan Phanuphak
Journal:  J Virus Erad       Date:  2018-04-01

5.  A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes.

Authors:  I Boucoiran; K Tulloch; N Pick; F Kakkar; J van Schalkwyk; D Money; M Boucher
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471

6.  Micronucleated erythrocytes in newborn rats exposed to raltegravir placental transfer.

Authors:  Blanca Miriam Torres-Mendoza; Damharis Elizabeth Coronado-Medina; Belinda Claudia Gómez-Meda; Eduardo Vázquez-Valls; Ana Lourdes Zamora-Perez; María de Lourdes Lemus-Varela; Guillermo Moisés Zúñiga-González
Journal:  Biomed Res Int       Date:  2014-05-25       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.